###begin article-title 0
Basal Cancer Cell Survival Involves JNK2 Suppression of a Novel JNK1/c-Jun/Bcl-3 Apoptotic Network
###end article-title 0
###begin p 1
Conceived and designed the experiments: SUA JM. Performed the experiments: SUA. Analyzed the data: SUA JM. Wrote the paper: JM.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 512 517 <span type="species:ncbi:9606">human</span>
The regulation of apoptosis under basal (non-stress) conditions is crucial for normal mammalian development and also for normal cellular turnover in different tissues throughout life. Deficient regulation of basal apoptosis, or its perturbation, can result in impaired development and/or disease states including cancer. In contrast to stress-induced apoptosis the regulation of apoptosis under basal conditions is poorly understood. To address this issue we have compared basal- and stress-induced apoptosis in human epithelial cells of normal and cancerous origins. For this purpose we focussed our study on the opposing pro-apoptotic JNK/anti-apoptotic NFkappaB pathways.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 318 323 <span type="species:ncbi:9606">human</span>
Combinatorial RNAi plus gene knockout were employed to access and map basal regulatory pathways of apoptosis. Follow-on, in-depth analyses included exogenous expression of phosphorylation mutants and chromatin immunoprecipitation. We demonstrate that basal apoptosis is constitutively suppressed by JNK2 in a range of human cancer cell lines. This effect was not observed in non-cancer cells. Silencing JNK2 by RNAi resulted in JNK1-dependent apoptosis of cancer cells via up-regulation of the AP-1 factor c-Jun. Unexpectedly we discovered that JNK1 and c-Jun promote basal apoptosis in the absence of "activating phosphorylations" typically induced by stress. Hypo-phosphorylated c-Jun accumulated to high levels following JNK2 silencing, auto-regulated its own expression and suppressed expression of Bcl-3, an unusual IkappaB protein and regulator of NFkappaB. Basal apoptosis was mediated by components of the TNFalpha response pathway but was mechanistically distinct from TNFalpha-induced apoptosis.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 473 478 <span type="species:ncbi:9606">human</span>
Our results demonstrate that mechanistically distinct pathways operate to regulate apoptosis in mammalian cells under basal (physiological) versus stress-induced conditions. We also describe a novel apoptotic network which governs the basal survival of cancer cells. Such information is crucial for understanding normal cellular turnover during mammalian development and subsequently throughout life. This information also opens new avenues for therapeutic intervention in human proliferative disease states including cancer.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Chang1">[1]</xref>
###xml 170 173 170 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Jaeschke1">[2]</xref>
###xml 319 322 319 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Sabapathy1">[3]</xref>
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Tournier1">[4]</xref>
###xml 760 763 760 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Hibi1">[5]</xref>
###xml 972 975 972 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Jaeschke1">[2]</xref>
###xml 977 980 977 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Yamamoto1">[6]</xref>
The c-Jun N-terminal kinases (JNKs) are members of the mitogen-activated protein kinase family (MAP kinases, MAPKs) and are activated in response to cellular stress [1], [2]. In response to stress JNK1 and JNK2 are activated via dual phosphorylation of T183 and Y185 by MAPK kinases (MAPKK), specifically MKK4 and MKK7 [3], [4]. MAPKs and MAPKKs form part of a signal transduction super-family that includes the extracellular signal-regulated kinases (ERKs) and p38 MAPK. The functions of JNK1 and JNK2 are determined by cell type and by the nature of the stress responsible for their activation. Initial studies identified JNKs by their ability to phosphorylate the N-terminus of c-Jun, a member of the activating protein 1 (AP-1) transcription factor family [5]. Subsequently JNKs were shown to phosphorylate and regulate the activity of other AP-1 proteins as well as additional proteins involved in cell proliferation and apoptosis including p53, c-Myc, Bcl-2 and Bim [2], [6].
###end p 9
###begin p 10
###xml 181 184 181 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Hess1">[7]</xref>
###xml 749 752 749 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Pulverer1">[8]</xref>
###xml 754 757 754 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Smeal1">[9]</xref>
###xml 942 946 942 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Wei1">[10]</xref>
AP-1 factors are a group of structurally and functionally related members of the Jun protein family (c-Jun, JunB and JunD) and the Fos protein family (c-Fos, FosB, Fra-1 and Fra-1) [7]. Dimerisation within these family members forms an AP-1 transcription factor and the relative abundance of individual AP-1 subunits and dimer composition are important factors determining cell fate. The repertoire of AP-1 dimer composition allows tailoring of an AP-1-mediated response by individual cell types to a given stimulus. Post-translational modification and protein turnover are two mechanisms for regulating AP-1 activity. For example, in response to stress the transactivation potential of c-Jun is activated by JNK-mediated N-terminal phosphorylation [8], [9], whereas the stability of c-Jun protein is down-regulated via GSK-3-mediated C-terminal phosphorylation which targets c-Jun for ubiquitinylation and degradation via the E3 ligase Fbw7 [10].
###end p 10
###begin p 11
###xml 204 208 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Mocellin1">[11]</xref>
###xml 554 562 534 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 567 574 547 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 708 711 684 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Chang1">[1]</xref>
###xml 713 717 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Gallagher1">[12]</xref>
###xml 949 952 925 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Chang1">[1]</xref>
###xml 954 958 930 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Wei1">[10]</xref>
###xml 1113 1117 1085 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Liu1">[13]</xref>
An important activator of the JNK apoptotic pathway is tumour necrosis factor alpha (TNFalpha), a pro-inflammatory cytokine that governs cell survival via promoting either cell proliferation or apoptosis [11]. TNFalpha engages with its trimeric receptor, TNFR1, at the external surface of the cell membrane. TNFalpha/TNFR1 interaction results in formation of an intracellular heterogeneous protein complex (complex 1) at the cytoplasmic tail of TNFR1. In its turn this complex leads to activation of JNK and also of IkappaB kinase (IKK). Elegant studies in vitro and in vivo have demonstrated that, in hepatocytes exposed to TNFalpha, activated JNK1 phosphorylates and activates the E3 ubiquitin ligase ITCH [1], [12]. Activated ITCH induces ubiquitinylation and degradation of cFLIP (cellular FLICE-inhibitory protein) which otherwise specifically inhibits activation of pro-caspase 8 (also called FLICE). Caspase 8 activation results in apoptosis [1], [10]. This pro-apoptotic pathway is counter-balanced by NFkappaB which up-regulates c-FLIP expression and thus inhibits pro-caspase 8 activation and apoptosis [13].
###end p 11
###begin p 12
###xml 171 175 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Ghosh1">[14]</xref>
###xml 846 850 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Franzoso1">[15]</xref>
###xml 852 856 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Wulczyn1">[16]</xref>
###xml 1258 1262 1195 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Michel1">[17]</xref>
###xml 1354 1358 1291 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Ohno1">[18]</xref>
NFkappaB is a transcription factor composed of homo- or heterodimers of members of the Rel family of proteins, including p65 (RelA), RelB, c-Rel, p50 and p52 (reviewed in [14]. Transcription activation domains are absent in p50 and p52 which thus need to form heterodimers in order to transactivate target genes. The principal assembly is a heterodimer of p65-p50 but different dimer compositions are also formed. NFkappaB is subject to regulation by protein-protein interactions with IkappaB proteins. IkappaBalpha and IkappaBbeta preferentially target p65-p50 heterodimers. Phosphorylation of IkappaB by IkappaB kinases triggers IkappaB degradation with release of dimeric NFkappaB which translocates into the nucleus and regulates gene expression. Bcl-3 is an unusual IkappaB which preferentially binds p50-p50 and p52-p52 NFkappaB homodimers [15], [16]. Bcl-3 is further distinguished from other IkappaB proteins in that it can localise to the nucleus, it is not degraded upon activation of NFkappaB and it possesses seven, rather than six, ankyrin repeat domains. Nuclear localisation of Bcl-3 is compatible with its ability to form a ternary complex with DNA-bound p50:p50 homodimers of NFkappaB, and also to assist uptake of p50 into the nucleus (see [17] and references therein). Bcl-3 was first described in B-cell chronic lymphocytic leukaemia [18] and is regarded as a putative oncoprotein.
###end p 12
###begin p 13
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Dong1">[19]</xref>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Tong1">[20]</xref>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
In addition to their roles in the stress response JNK1 and JNK2 also function under basal, non-stress conditions as evidenced by tissue-specific abnormalities observed in JNK1-/- and JNK2-/- mice. For example, JNK1-/- mice exhibit decreased T-cell differentiation and defective immunity [19]. Importantly JNK1-/- mice also develop spontaneous intestinal tumours, indicating that JNK1 functions as a tumour suppressor for this tissue type [20]. However, the mechanisms of JNK1 and JNK2 functioning under basal, physiological conditions are poorly understood.
###end p 13
###begin p 14
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 265 270 <span type="species:ncbi:9606">human</span>
To investigate the individual roles of JNK1 and JNK2 in human epithelial cells under basal conditions we employed a combination of (i) RNAi induced in the absence of applied stress, (ii) gene knock-out cell lines, and (iii) exogenous gene expression. In a range of human cell lines we discovered that JNK1 is actively pro-apoptotic but is constitutively inhibited by the presence of JNK2 in cancer cells. This effect was not observed in non-cancer cells. Co-silencing experiments revealed that these basal, opposing pro- and anti-apoptotic functions of JNK1 and JNK2 are largely independent of up-stream kinases MKK4 and MKK7. This was consistent with lack of discernable change in JNK1 phosphorylation despite JNK1-dependent apoptosis following depletion of JNK2. Further experiments revealed that the basal JNK1 pro-apoptotic pathway involves c-Jun plus components of the TNFalpha-responsive MAP kinase pathway coupled with the NFkappaB pathway via c-Jun-mediated down-regulation of Bcl-3. Thus the basal regulation of cancer cell survival appears to be dependent upon the opposing functions of JNK2/Bcl-3 (pro-survival) and JNK1/c-Jun (pro-apoptotic) and to be under constitutive control by JNK2.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
Selective knock-down of JNK2 enhances JNK1 expression
###end title 16
###begin p 17
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Allison1">[21]</xref>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Ford1">[22]</xref>
###xml 422 429 422 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 533 540 533 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 545 552 545 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007305.s002">Fig. S1</xref>
###xml 696 703 684 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1A</xref>
###xml 813 817 801 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WAF1</sup>
###xml 848 855 836 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1B</xref>
###xml 875 882 863 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007305.s003">Fig. S2</xref>
###xml 949 955 937 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 1077 1084 1053 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1B</xref>
###xml 1253 1257 1229 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Fuchs1">[23]</xref>
###xml 1332 1339 1308 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1B</xref>
For RNAi we employed synthetic siRNAs under conditions previously demonstrated to give efficient knock-down of target mRNAs without activation of the p53 cellular stress response [21], [22]. RNAi controls included BCR-ABL siRNA, which has no mRNA target in epithelial cells and therefore serves as a non-functional siRNA control, and lamin A/C siRNA, which targets lamin A/C mRNA and serves as a functional siRNA control (Methods). Selective knock-down of JNK1 and JNK2 mRNA was reproduced with two different siRNAs for each target (Methods and Fig. S1). The efficiency of mRNA knock-down was determined by quantitative PCR and was similar for both JNK1 and JNK2 (approximately75% reduction; see Fig. 1A for JNK1 mRNA levels). RNAi-induced silencing of lamin A/C or of JNK1 did not induce any change in p53 or p21WAF1, a p53-dependent target gene (Fig. 1B for JNK1 siRNA and Fig. S2 for lamin A/C siRNA), thus confirming that the conditions of RNAi per se do not initiate a p53 stress response. However JNK2 silencing resulted in a approximately3 fold increase in p53 protein (Fig. 1B) suggesting that JNK2 directly or indirectly regulates the turnover of p53 protein. This is consistent with the report that JNKs can regulate the basal turnover of p53 [23]. Interestingly, co-silencing of JNK1 with JNK2 abrogated the rise in p53 (Fig. 1B) implying that JNK1 and JNK2 exert co-ordinated effects upon the turnover of p53.
###end p 17
###begin title 18
###xml 69 74 <span type="species:ncbi:9606">human</span>
JNK2 constitutively suppresses JNK1-mediated apoptosis in a range of human cancer cell lines but not in non-cancer cells.
###end title 18
###begin p 19
###xml 154 161 154 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 392 399 392 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 827 834 827 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 374 379 <span type="species:ncbi:9606">human</span>
###xml 789 794 <span type="species:ncbi:9606">human</span>
(A) JNK1 mRNA levels, and (B) JNK1, JNK2, and also p53 and p21 protein levels determined 48 h after transfection with JNK1- and JNK2-siRNAs as indicated (Methods). (C) Phase contrast images of HCT116 cells 48 h after transfection with JNK1- and JNK2-siRNAs. (D) Apoptosis determined by annexin V labelling of siRNA-treated cells relative to untreated controls in a range of human cell lines (Methods. Note: apoptosis results are representative of at least three repeat experiments unless error bars are included for repeat analyses of a single experiment). (E) Caspase 8 and its cleavage products, activated caspase 7 and effector caspase 3 following RNAi-mediated silencing of JNK1 and JNK2 as indicated. Actin  =  loading controls. HCT116 p53+/+ and HCT116 p53-/- are isogenic clones of human HCT116 colorectal cancer cells (Methods).
###end p 19
###begin p 20
###xml 196 210 172 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1A and 1B</xref>
###xml 279 282 255 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 297 300 273 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 308 322 284 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1A and 1B</xref>
Unexpectedly, in HCT116 colorectal cancer cells JNK2 knock-down consistently resulted in a approximately50% increase in JNK1 mRNA levels and a approximately3 fold increase in JNK1 protein levels (Fig. 1A and 1B). Similar results for JNK1 mRNA were obtained in isogenic HCT116 p53+/+ and HCT116 p53-/- cells (Fig. 1A and 1B), indicating that the effect is p53-independent. Thus, in HCT116 cells, the presence of JNK2 directly or indirectly suppresses basal JNK1 expression levels.
###end p 20
###begin title 21
JNK2 knock-down induces apoptosis
###end title 21
###begin p 22
###xml 97 111 97 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1C and 1D</xref>
###xml 162 169 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 240 247 240 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1E</xref>
###xml 350 364 350 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1C and 1D</xref>
###xml 527 534 527 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1D</xref>
###xml 667 681 667 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1C and 1D</xref>
###xml 788 793 <span type="species:ncbi:9606">human</span>
Knock-down of JNK2 resulted in apoptosis in a range of cancer cell lines including HCT116 cells (Fig. 1C and 1D). Apoptosis was determined by annexin V staining (Methods) and involved pro-caspase 8 activation and effector caspases 3 and 7 (Fig. 1E). This apoptotic effect of JNK2 depletion was independent of p53 as evidenced by HCT116 p53-/- cells (Fig. 1C and 1D). In non-cancer cells JNK2 silencing did not induce apoptosis (ARPE19 and MCF10A epithelial cells, and WI-38 fibroblasts) despite efficient JNK2 mRNA knock-down (Fig. 1D and data not shown). In contrast to JNK2 silencing, the silencing of JNK1 did not affect viability in any of the cell lines tested (Fig. 1C and 1D). Overall these results indicate that JNK2, but not JNK1, is essential for basal viability in a number of human cancer cell lines including MCF7 breast cancer epithelial cells, but is dispensable for basal viability of non-cancer cells including MCF10A breast epithelial cells.
###end p 22
###begin title 23
Apoptosis is JNK1-dependent
###end title 23
###begin p 24
###xml 265 272 265 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1D</xref>
We next co-silenced JNK1 with JNK2 in order to investigate their functional linkage in the regulation of cancer cell survival. In all cases where JNK2 silencing induced apoptosis we found that co-silencing JNK1 with JNK2 rescued JNK2-depleted cells from apoptosis (Fig. 1D). Thus we conclude that JNK1 and JNK2 counter-balance each other in the maintenance of cancer cell viability and that JNK2 constitutively suppresses JNK1-mediated apoptosis under basal conditions.
###end p 24
###begin title 25
JNK1-dependent apoptosis is independent of enhanced JNK1 S63/73 phosphorylation
###end title 25
###begin p 26
###xml 312 324 312 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
The above results indicate that JNK1 is primed to induce apoptosis in human epithelial cancer cells but is constitutively suppressed by JNK2. Both JNK1 and JNK2 are downstream mediators of the MAP kinase apoptotic pathway and are activated in response to stress by MKK4 and/or MKK7 phosphorylation at T183/Y185 (Introduction). We next compared JNK1 and JNK2 phosphorylation under basal (RNAi) and stress-induced (UV or TNFalpha) conditions.
###end p 26
###begin p 27
###xml 128 135 128 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2A</xref>
###xml 246 253 242 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2B</xref>
As expected UV irradiation induced strong phosphorylation at residues T183/Y185 of both JNK1 and JNK2 proteins in HCT116 cells (Fig. 2A). Similarly, treatment of HCT116 cells with TNFalpha also induced JNK1 and JNK2 phosphorylation at T183/Y185 (Fig. 2B, upper panel). In this latter instance JNK1 phosphorylation predominated over JNK2 phosphorylation. These results clearly demonstrate phosphorylation of JNK1 and JNK2 in response to genotoxic stress (UV) and to receptor-mediated stress (TNFalpha) in HCT116 cells. Both UV-irradiation and TNFalpha induced apoptosis (data not shown).
###end p 27
###begin title 28
JNK1 and c-Jun, required for basal apoptosis, remain hypo-phosphorylated following JNK2 silencing whereas both are hyper-phosphorylated in response to stress.
###end title 28
###begin p 29
###xml 121 128 121 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 370 377 366 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
(A) Comparison of JNK1/JNK2 phosphorylation status in control, JNK2-silenced and following UV-irradiation (HCT116 cells; Methods). p-JNK1  =  phosphorylated JNK1, pJNK2  =  phosphorylated JNK2 (arrowed). (B) Effects of TNFalpha on phosphorylation status of JNK1, JNK2 and c-Jun. (C) Co-silencing c-Jun with JNK2 rescues HCT116 cells from apoptosis (annexin V labelling; Methods). (D) JNK1, JNK2 and c-Jun protein levels 48 h post RNAi-mediated silencing of JNK2 and c-Jun. P53 and p21 protein levels are also shown. (E) c-Jun mRNA levels after JNK1 and JNK2 silencing. (F) Fold increase in c-Jun mRNA levels in HCT116 cells compared with ARPE19 cells 48 h after JNK2 silencing. (G) Knockdown of c-Jun mRNA and protein levels in HCT116 p53+/+ cells following c-Jun siRNA treatment.
###end p 29
###begin p 30
###xml 156 163 156 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2A</xref>
###xml 268 275 268 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2A</xref>
###xml 590 597 590 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007305.s004">Fig. S3</xref>
Under basal conditions, when JNK1 was actively pro-apoptotic following JNK2 silencing, there was no discernable increase in JNK1 T183/Y185 phosphorylation (Fig. 2A, compare control lane with JNK2 siRNA lane). This is in striking contrast to stress-induced conditions (Fig. 2A; compare JNK2 siRNA lane with UV lane). Thus we infer that JNK1 is able to promote apoptosis in the absence of 'activating' T183/Y185 phosphorylations that are characteristically induced in response to stress. Co-silencing up-stream kinases MKK4 or MKK 7 with JNK2 only partially rescued JNK1-dependent apoptosis (Fig. S3), further substantiating the ability of JNK1 to promote apoptosis in the absence of enhanced T183/Y185 phosphorylations.
###end p 30
###begin p 31
###xml 236 241 <span type="species:ncbi:9606">human</span>
We conclude that, under basal conditions, JNK1 can actively promote apoptosis without undergoing enhanced T183/Y185 phosphorylation characteristic of the cellular stress response. This basal pro-apoptotic function of JNK1 is evident in human epithelial cancer cells (but not in non-cancer cells) and is constitutively inhibited by endogenous JNK2. To investigate the basal apoptotic pathway under JNK1 control we next carried out a series of co-silencing experiments aimed at identifying essential pro-apoptotic mediators linked with the JNK1-dependent apoptosis following JNK2 silencing.
###end p 31
###begin title 32
c-Jun is an essential mediator of basal apoptosis and is subject to opposing effects of JNK1 and JNK2
###end title 32
###begin p 33
###xml 97 103 97 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2</xref>
###xml 156 163 156 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2G</xref>
###xml 385 392 385 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2C</xref>
To ask if c-Jun is required for apoptosis under basal conditions we co-silenced c-Jun with JNK2 (Fig. 2; the efficiency of c-Jun mRNA knockdown is shown in Fig. 2G). The results clearly demonstrate that c-Jun co-silencing rescues JNK2-silenced HCT116 cells from apoptosis thus identifying c-Jun as an essential mediator of apoptosis subject to JNK2 suppression under basal conditions (Fig. 2C).
###end p 33
###begin p 34
###xml 87 94 87 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2D</xref>
###xml 230 237 230 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2E</xref>
###xml 318 325 318 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3A</xref>
###xml 348 355 348 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2E</xref>
###xml 527 534 527 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2E</xref>
###xml 539 546 539 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007305.s005">Fig. S4</xref>
###xml 866 869 866 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 884 887 884 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 911 918 911 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2E</xref>
###xml 1012 1019 1012 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2F</xref>
###xml 1071 1078 1071 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1D</xref>
The c-Jun protein accumulated to high levels following JNK2 silencing in HCT116 cells (Fig. 2D; increased c-Jun was also observed in RKO and Lovo cells following JNK2 silencing, not shown) paralleled by an increase in c-Jun mRNA (Fig. 2E). Interestingly, this effect was abolished when JNK1 was co-silenced with JNK2 (Fig. 3A for c-Jun protein and Fig. 2E for c-Jun mRNA) indicating that up-regulation of c-Jun is dependent upon the continued presence of JNK1. JNK1 silencing alone caused a decrease in c-Jun mRNA and protein (Fig. 2E and Fig. S4). These combined observations indicate that JNK1 and JNK2 exert opposing effects upon c-Jun expression and that JNK1 is required for maintenance of basal c-Jun mRNA and protein expression levels, whilst JNK2 constitutively suppresses c-Jun mRNA and protein expression levels. Similar results were observed in HCT116 p53+/+ and HCT116 p53-/- cells (see for example Fig. 2E). Interestingly increased c-Jun mRNA levels were not observed in JNK2-silenced ARPE19 cells (Fig. 2F) consistent with lack of apoptosis in these cells (Fig. 1D).
###end p 34
###begin title 35
Hypo-phosphorylated c-Jun protein accumulates to high levels following JNK2 silencing, this effect is dependent upon JNK1 and correlates with c-Jun chromatin binding at the c-Jun promoter in HCT116 cells.
###end title 35
###begin p 36
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-Jun</italic>
###xml 472 479 472 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
(A) Total c-Jun protein and phosphorylations at S63, S73 and T91 following either UV-irradiation (right hand lane) or JNK1 and JNK2 RNAi-induced silencing. (B) Schematic showing c-Jun and the amplicon used for detecting c-Jun on the promoter. (C) Total and phosphorylated forms of c-Jun bound at the c-Jun promoter detected by chromatin immunoprecipitation (ChIP) with c-Jun and c-Jun phospho-specific antibodies. Histogram shows fold-enrichment relative to IgG controls (Methods).
###end p 36
###begin p 37
###xml 232 235 232 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Jaeschke1">[2]</xref>
Our results identify opposing effects of JNK1 and JNK2 on c-Jun. In this respect they differ from observations obtained using a 'chemical genetics' approach in which the catalytic ATP-binding pocket of JNK2 was expanded by mutation [2]. The conclusion from this latter approach was that JNK1 and JNK2 both positively regulate c-Jun expression. However, it is possible that expansion of the ATP-binding pocket of JNK2 may perturb the spatial molecular organisation of the adjacent beta-strand-like region of JNK2 protein. Since this beta-strand-like domain is important for JNK2 protein-protein interactions we suggest that localised perturbation at this site may compromise the binding characteristics of JNK2 protein for its target substrates. This might affect the functioning of mutant JNK2 in ways additional to the predicted effects on molecular access into the expanded ATP binding pocket of JNK2.
###end p 37
###begin p 38
###xml 155 158 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Sabapathy1">[3]</xref>
###xml 24 30 <span type="species:ncbi:10090">murine</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Another study comparing murine fibroblasts derived from JNK1-/- and JNK2-/- mice indicated that JNK1 and JNK2 can function as opposing regulators of c-Jun [3]. Our own results, under basal conditions, are consistent with this report and show that in HCT116 cells (i) JNK2 silencing results in up-regulation of c-Jun mRNA accompanied marked accumulation of c-Jun protein, and (ii) up-regulation of c-Jun under these conditions is dependent upon JNK1.
###end p 38
###begin title 39
Up-regulation of JNK1 in JNK2-depleted cells is independent of c-Jun
###end title 39
###begin p 40
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1B</xref>
###xml 334 341 334 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2D</xref>
Given that basal up-regulation of c-Jun (in JNK2-depleted cells) requires JNK1 (see above) we wondered if c-Jun, in its turn, is required for the up-regulation of JNK1 protein following JNK2 silencing (Fig. 1B). However the increase in JNK1 consistently observed in JNK2-silenced cells was unaffected by co-silencing c-Jun with JNK2 (Fig. 2D; upper panel). This indicates that enhanced mRNA and protein expression of JNK1 following JNK2 depletion is independent of c-Jun.
###end p 40
###begin title 41
Hypo-phosphorylated c-Jun binds the c-Jun promoter
###end title 41
###begin p 42
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Weiss1">[24]</xref>
###xml 270 277 270 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3A</xref>
###xml 370 377 370 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3A</xref>
###xml 480 487 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3A</xref>
Stress-induced S63/S73 phosphorylation of c-Jun by JNK kinases releases c-Jun from an inhibitory complex thus enabling c-Jun to bind and transactivate target promoters [24]. Stress-induced phosphorylation of c-Jun in HCT116 cells treated with UV-irradiation is shown in Fig. 3A. However, although we observed high accumulation of c-Jun protein following JNK2 silencing (Fig. 3A; JNK2 siRNA lane) this was independent of increased N-terminal phosphorylation at S63, S73 or at S91 (Fig. 3A).
###end p 42
###begin p 43
###xml 74 81 74 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2E</xref>
###xml 290 304 290 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3B and 3C</xref>
###xml 379 386 379 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3C</xref>
###xml 465 472 465 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3A</xref>
###xml 611 618 611 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3C</xref>
###xml 749 756 749 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3A</xref>
###xml 825 832 825 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3C</xref>
###xml 967 974 967 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3C</xref>
###xml 1267 1274 1255 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g002">Fig. 2E</xref>
JNK2 silencing induces a marked increase in c-Jun mRNA levels (see above, Fig. 2E). To ask if increased c-Jun transcripts were attributable, at least in part, to a positive auto-regulatory feed-back loop we performed chromatin immunoprecipitation (ChIP) for c-Jun/c-Jun promoter complexes (Fig. 3B and 3C). In untreated HCT116 cells c-Jun was undetectable at the c-Jun promoter (Fig. 3C, controls). Following UV-irradiation c-Jun was phosphorylated at S63 and S73 (Fig. 3A) and the phosphorylated protein was bound at the c-Jun promoter as indicated by ChIP analysis using anti-phospho-T63/73 c-Jun antibodies (Fig. 3C). In JNK2-depleted cells, under basal conditions, no change in c-Jun T63/73 phosphorylation was evident relative to the controls (Fig. 3A). Nonetheless c-Jun in these cells was bound at the c-Jun promoter (Fig. 3C). Lack of phosphorylation of the chromatin-bound c-Jun was confirmed by lack of reactivity with anti-phospho-T63/73 c-Jun antibodies (Fig. 3C; compare samples from UV-irradiated cells with JNK2-silenced cells). Thus we conclude that S63/73 hypo-phosphorylated c-Jun binds to its own promoter following JNK2 depletion and is likely to contribute to the high c-Jun mRNA expression levels (approximately9-fold increase over control, see Fig. 2E) induced under these basal conditions.
###end p 43
###begin title 44
c-Jun protein accumulation correlates with loss of phosphorylation at S243
###end title 44
###begin p 45
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Wei1">[10]</xref>
###xml 547 557 547 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g004">Fig. 4B&#8211;4D</xref>
###xml 757 767 757 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g004">Fig. 4B&#8211;4D</xref>
It is possible that c-Jun is maintained at low levels in HCT116 cells, lower than observed for non-cancer ARPE19 cells (data not shown), via continual c-Jun protein degradation. Degradation of c-Jun involves C-terminal phosphorylation at S243 which primes c-Jun for GSK3-mediated phosphorylation at T239. This generates an attachment site for the Fbw7 E3 ubiquitin ligase, resulting in polyubiquitinylation and c-Jun degradation [10]. In our present study we noted that JNK1 silencing caused a slight but reproducible increase in c-Jun S243P (see Fig. 4B-4D; control lane cp JNK1 siRNA lane S243P immunoblots). Conversely JNK2 silencing reproducibly caused reduced levels of c-Jun 243P, sometimes undetectable despite massive accumulation of total protein (Fig. 4B-4D; control lane cp JNK2 siRNA for S243P immunoblots). Thus JNK1 and JNK2 exert opposing effects upon c-Jun phosphorylation at S243, a modification linked with de-stabilisation of c-Jun protein.
###end p 45
###begin title 46
GSK3, ERK and Fbw7 are essential basal pro-apoptotic mediators following JNK2 silencing but are without apparent effect upon their stress-associated substrate c-Jun.
###end title 46
###begin p 47
(A) Schematic showing sites of phosphorylation of c-Jun by JNK, GSK-3 and ERK, and their respective functional consequences. Note that S243P is a pre-requisite of T239 phosphorylation (indicated by curved arrow). (B) Immunoblots showing effects of JNK1, JNK2 and GSK3 silencing, alone and in combinations, on a panel of HCT116 cellular proteins. (C) and (D) Immunoblots following combinatorial silencing of JNK1 and JNK2 with Fbw7 and ERK. (E) Essential pro-apoptotic intermediates determined by co-silencing with JNK2. (F) Apoptosis following JNK2 silencing under basal conditions is independent of Bax as evidenced by Bax+/- and Bax-/- HCT116 isogenic clones.
###end p 47
###begin title 48
GSK3, ERK, Fbw7 and ITCH are essential mediators of basal JNK1-dependent apoptosis
###end title 48
###begin p 49
###xml 200 207 200 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g004">Fig. 4E</xref>
###xml 327 345 327 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g004">Fig. 4B, 4C and 4D</xref>
###xml 591 595 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Wei1">[10]</xref>
###xml 597 601 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Anzi1">[25]</xref>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Morton1">[26]</xref>
In a further series of co-silencing experiments we demonstrate that kinases GSK3, ERK, and the ubiquitin 3 ligase Fbw7 are also essential mediators of JNK1-dependent apoptosis in JNK2-depleted cells (Fig. 4E). However none of these components appeared to impinge upon S243 phosphorylation or accumulation of the c-Jun protein (Fig. 4B, 4C and 4D; lanes GSK3, Fbw7 and ERK respectively). This was unexpected since, in response to stress, all three have been linked with c-Jun degradation via S239 and S243 phosphorylation (ERK and GSK3 respectively) and ubiquitin-mediated degradation (Fbw7) [10], [25], [26]. It seems that, under basal conditions, GSK3, ERK and Fbw7 function as essential mediators of apoptosis via substrates other than c-Jun.
###end p 49
###begin title 50
Bax and CKII are dispensable for the basal JNK1/JNK2 apoptotic pathway
###end title 50
###begin p 51
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Lei1">[27]</xref>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Zong1">[28]</xref>
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Jaeschke1">[2]</xref>
###xml 273 276 273 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 291 294 291 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 302 309 302 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g004">Fig. 4F</xref>
###xml 438 441 438 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Sabapathy1">[3]</xref>
###xml 508 515 508 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g004">Fig. 4E</xref>
Following stress Bax is a pro-apoptotic mediator of JNK-induced apoptosis [27], [28]. To ask if Bax is also required for the basal JNK1/JNK2-regulated apoptotic pathway we used isogenic Bax+/- and Bax-/- HCT116 cells [2]. JNK2 silencing induced apoptosis in both HCT116 Bax+/- and HCT116 Bax-/- cells (Fig. 4F) indicating that Bax is not required for apoptosis under these basal conditions. Co-silencing CKII, a putative kinase for c-Jun [3], also failed to rescue JNK2-depleted HCT116 cells from apoptosis (Fig. 4E). Thus both Bax and CKII appear dispensable for the basal JNK1/JNK2 apoptotic pathway.
###end p 51
###begin title 52
Interaction between c-Jun and ITCH
###end title 52
###begin p 53
###xml 162 174 158 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 356 370 352 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g005">Fig. 5A and 5B</xref>
The pro-apoptotic pathway induced by TNFalpha culminates in phosphorylated JNK1-dependent activation of ITCH, degradation of c-FLIP and caspase 8 activation (see Introduction). Here we show that ITCH is also an essential pro-apoptotic mediator governed by JNK1/JNK2 under basal conditions and that co-silencing ITCH with JNK2 rescues cells from apoptosis (Fig. 5A and 5B).
###end p 53
###begin title 54
c-Jun is complexed with ITCH under basal condition and released following JNK2 silencing.
###end title 54
###begin p 55
(A) and (B) Protein and apoptotic levels observed following ITCH and JNK2 silencing in HCT116 cells. (C) Complexes of endogenous ITCH-c-Jun proteins detected prior to JNK2 silencing are lost following JNK2 depletion.
###end p 55
###begin p 56
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g005">Fig. 5C</xref>
###xml 362 369 362 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g005">Fig. 5C</xref>
To further investigate the pro-apoptotic role of ITCH under basal conditions we performed immunoprecipitation/immunoblot analysis for endogenous complexes of ITCH-c-Jun before and after RNAi-mediated silencing of JNK2 (Fig. 5C). Significantly, ITCH-c-Jun complexes were detectable under control conditions but these complexes were lost following JNK2 silencing (Fig. 5C).
###end p 56
###begin title 57
Apoptosis proceeds via c-FLIP and caspase 8
###end title 57
###begin p 58
###xml 63 70 63 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g004">Fig. 4E</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Wilson1">[29]</xref>
###xml 359 366 359 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g006">Fig. 6A</xref>
###xml 457 464 457 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g007">Fig. 7A</xref>
###xml 648 662 648 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g006">Fig. 6A and 6B</xref>
Co-silencing caspase 8 with JNK2 rescued cells from apoptosis (Fig. 4E). This effect was restricted to basal conditions since caspase 8 RNAi failed to rescue apoptosis following UV irradiation (data not shown). c-FLIP silencing alone induced apoptosis in HCT116 cells [29]. Co-silencing c-Jun, GSK3, or Fbw7 with c-FLIP failed to rescue cells from apoptosis (Fig. 6A), indicating that each of these pro-apoptotic intermediates function up-stream of c-FLIP (Fig. 7A-schematic). Thus basal and stress-induced apoptotic MAP kinase pathways converge at the level of c-FLIP. As expected, co-silencing caspase 8 with c-FLIP rescued cells from apoptosis (Fig. 6A and 6B).
###end p 58
###begin title 59
###xml 54 59 <span type="species:ncbi:9606">human</span>
c-FLIP is an essential mediator of basal apoptosis in human cancer cells and functions downstream of GSK3, Fbw7, c-Jun and JNK1.
###end title 59
###begin p 60
(A) Levels of apoptosis observed following co-silencing of c-FLIP with pro-apoptotic mediators. (B) Protein levels showing pro-caspase 8 cleavage and c-Jun accumulation following c-FLIP depletion by RNAi.
###end p 60
###begin title 61
c-Jun overexpression induces apoptosis in HCT116 p53+/+ cells but not in ARPE-19 cells.
###end title 61
###begin p 62
###xml 428 449 428 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">materials and methods</xref>
(A) Schematic showing wild type c-Jun (wt-c-Jun) and non-phosphorylatable mutant c-Jun constructs. (B) Annexin V measurement of apoptosis following overexpression of wt-c-Jun or mut-c-Jun as indicated. (C) Immunoblots showing total and phosphorylated c-Jun following overexpression, SIRT1 loading control shown. (D) Levels of apoptosis following combined siRNA treatment in the presence or absence of non-target mut-c-Jun, (see materials and methods).
###end p 62
###begin title 63
Over-expression of exogenous c-Jun induces apoptosis
###end title 63
###begin p 64
###xml 176 190 176 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g007">Fig. 7A and 7B</xref>
###xml 424 438 424 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g007">Fig. 7A and 7B</xref>
###xml 541 545 541 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Ford1">[22]</xref>
###xml 741 748 741 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g007">Fig. 7C</xref>
###xml 1029 1036 1029 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3A</xref>
###xml 1296 1303 1296 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g007">Fig. 7C</xref>
###xml 1480 1490 1480 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g004">Fig. 4B-4D</xref>
###xml 1621 1628 1621 1628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g007">Fig. 7B</xref>
We next asked if high level expression of c-Jun alone is sufficient to induce apoptosis. Over-expression of exogenous wild type c-Jun induced apoptosis in HCT116 cancer cells (Fig. 7A and 7B). Importantly, over-expression of a c-Jun phosphorylation mutant, in which S63, S73, T91 and T93 are all mutated to alanine, also induced apoptosis thus re-enforcing evidence for pro-apoptotic functions of hypo-phosphorylated c-Jun (Fig. 7A and 7B). Note that exogenous expression of another protein, SIRT1, does not induce apoptosis in HCT116 cells [22] indicating that the present results are specific to c-Jun. Protein expression from the c-Jun constructs and phosphorylation status shows phosphorylation at all sites examined on wild type c-Jun (Fig. 7C). This is indicative of cellular stress in response to exogenous gene over-expression. Note that this is in contrast to the sustained c-Jun hypo-phosphorylated status following RNAi-mediated gene silencing under the basal conditions employed throughout this work (see for example Fig. 3A). The c-Jun phosphorylation mutant lacked reactivity with anti-phospho-S63, S73 and T91 antibodies as expected (antibody to phosphoserine 93 was not available). Although both mutant and wild type exogenous c-Jun proteins were phosphorylated at T239 and S243 (Fig. 7C) we believe that this was non-essential for induction of apoptosis since endogenous c-Jun is required for apoptosis despite lack of C-terminal phosphorylation (see for example Fig. 4B-4D following JNK2 silencing). Significantly, over-expression of exogenous c-Jun did not induce apoptosis in non-cancer ARPE19 cells (Fig. 7B). These overall observations further re-enforce our conclusions (i) that elevated levels of hypo-phosphorylated c-Jun are pro-apoptotic in HCT116 cancer cells, and (ii) that the effect is specific for cancer cells (HCT116) and is not observed in non-cancer cells (ARPE19).
###end p 64
###begin title 65
Effects of c-Jun silencing are not attributable to off-target effects of c-Jun siRNA
###end title 65
###begin p 66
###xml 440 447 440 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 570 584 570 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g007">Fig. 7A and 7B</xref>
###xml 721 728 721 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g007">Fig. 7D</xref>
###xml 876 883 876 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g007">Fig. 7D</xref>
The ability to rescue JNK2-depleted cells from apoptosis by combinatorial siRNA-induced gene silencing is strong evidence that our above results reflect specific gene silencing rather than general off-target effects of RNAi. This was confirmed for c-Jun by selective RNAi-targetting of endogenous wild type c-Jun in cells expressing an exogenous pro-apoptotic c-Jun mutant lacking a complementary mRNA recognition site for the c-Jun siRNA (Methods). For this purpose we used the c-Jun phosphorylation mutant already shown to be pro-apoptotic in HCT116 cells (see above; Fig. 7A and 7B). As before, JNK2 silencing alone induced apoptosis whilst co-silencing JNK2 with endogenous c-Jun rescued HCT116 cells from apoptosis (Fig. 7D). However, in those cells expressing the exogenous non-target c-Jun mRNA, wild-type c-Jun/JNK2 co-silencing failed to rescue cells from apoptosis (Fig. 7D). These results confirm that the observed effects of c-Jun silencing are attributable to selective gene silencing rather than to non-selective off-target effects of RNAi.
###end p 66
###begin title 67
Non-phosphorylated c-Jun accumulates in the insoluble nuclear fraction following JNK2 silencing
###end title 67
###begin p 68
###xml 326 333 326 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8A</xref>
###xml 462 469 462 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8A</xref>
###xml 604 616 604 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 799 806 799 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8A</xref>
###xml 914 921 914 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8A</xref>
###xml 1100 1107 1096 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8A</xref>
###xml 1397 1403 1393 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g003">Fig. 3</xref>
###xml 1627 1634 1623 1630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8A</xref>
###xml 1639 1646 1635 1642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007305.s006">Fig. S5</xref>
JNK2 silencing results in high level accumulation of non-phosphorylated c-Jun in HCT116 cancer cells (see above). Cell fractionation studies revealed that most, if not all, of the non-phosphorylated c-Jun protein accumulates in the nuclei of JNK2-silenced cells and selectively associates with the insoluble nuclear fraction (Fig. 8A). Prior to JNK2 silencing the c-Jun protein, present at low levels in HCT116 cells, predominated in the nucleoplasmic fraction (Fig. 8A). The accumulated hypo-phosphorylated c-Jun was physically separated from GSK3 and ERK, two kinases that can phosphorylate c-Jun (see Introduction), and also from ITCH, an E3 ligase involved in JNK1-mediated apoptosis: GSK3, ERK and ITCH all localised largely to the cytoplasmic fraction both before and after depletion of JNK2 (Fig. 8A). For ERK some additional protein was detectable in the soluble nuclear fraction following JNK2 silencing (Fig. 8A). The localisation of NFkappaB family members also showed little change following JNK2 silencing with the exception of p65 which showed some binding within the nuclear fraction (Fig. 8A). The insoluble nature of c-Jun's nuclear localisation following JNK2 silencing indicates that the accumulated hypo-phosphorylated c-Jun is complexed with sub-nuclear structures and/or chromatin. This is likely to include hypophosphoryated c-Jun bound at the c-Jun promoter (see above and Fig. 3). Non-cancer ARPE19 cells showed different sub-cellular localisations compared with HCT116 cancer cells in that c-Jun and Bcl-3 proteins were localised in the nuclear soluble and insoluble fractions under basal conditions (Fig. 8A and Fig. S5).
###end p 68
###begin title 69
Non-phosphorylated c-Jun accumulates in the insoluble nuclear fraction following JNK2 silencing and down-regulates Bcl-3 expression in HCT116 p53+/+ cells.
###end title 69
###begin p 70
(A) Nuclear and cytoplasmic preparations following control and JNK2 siRNA treatment. Immunoblots show protein levels in the fractions indicated, equivalent cell number per lane. Histone H3 (nuclear insoluble) and 14-3-3sigma (cytoplasmic) fractionation controls. (B and C) Quantitative PCR analysis of Fas and Bcl-3 mRNA. (D) Bcl-3 protein levels following siRNA treatment. (E) Levels of apoptosis following Bcl-3 or combined Bcl-3 and c-Jun siRNA treatment. (F) Immunoblots showing levels of Bcl-3 following siRNA treatment.
###end p 70
###begin title 71
JNK2 enhances, whilst c-Jun suppresses expression of Bcl-3, a pro-survival IkappaB protein
###end title 71
###begin p 72
###xml 299 313 299 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8B and 8C</xref>
###xml 564 578 564 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8B and 8C</xref>
In an attempt to identify down-stream targets of JNK2/c-Jun we next screened for AP-1 targets reciprocally responsive to JNK2 and c-Jun silencing but with little or no response to combined JNK2 plus c-Jun co-silencing. We identified two AP-1 targets as fitting these criteria: namely FAS and Bcl-3 (Fig. 8B and 8C). It is well established that FAS is pro-apoptotic and, consistent with this, FAS expression was up-regulated upon JNK2 silencing, down-regulated upon c-Jun silencing, and these opposing effects were cancelled following JNK2 plus c-Jun co-silencing (Fig. 8B and 8C). These results indicate that up-regulation of FAS following JNK2 silencing is c-Jun-dependent.
###end p 72
###begin p 73
###xml 180 194 180 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8C and 8D</xref>
###xml 234 241 234 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8F</xref>
###xml 445 459 445 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8C and 8D</xref>
In contrast Bcl-3 appeared to be down-regulated by c-Jun. Thus, c-Jun silencing resulted in increased Bcl-3 expression whilst JNK2 silencing correlated with Bcl-3 down-regulation (Fig. 8C and 8D). JNK1 silencing also increased Bcl-3 (Fig. 8F) consistent with its positive role in basal c-Jun functions. Bcl-3 down-regulation was clearly dependent upon c-Jun since co-silencing c-Jun with JNK2 negated their opposing effects on Bcl-3 expression (Fig. 8C and 8D). Thus JNK-2 silencing in HCT116 cancer cells causes down-regulation of Bcl-3 expression and this effect is mediated via c-Jun.
###end p 73
###begin title 74
Bcl-3 and c-Jun are pivotal in basal cancer cell survival
###end title 74
###begin p 75
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8E</xref>
###xml 268 275 268 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8E</xref>
Since Bcl-3 has been implicated in abnormal cell survival we next asked if Bcl-3 is required for the survival of HCT116 cancer cells. RNAi-mediated silencing of Bcl-3 induced apoptosis in HCT116 cells (Fig. 8E). This effect could not be rescued by co-silencing c-Jun (Fig. 8E), indicating that the pro-survival function of Bcl-3 is down-stream of c-Jun. Our results suggest that the c-Jun pro-apoptotic mechanism operates, at least in part, via c-Jun-dependent down-regulation of Bcl-3. These observations are important and link the basal JNK2-mediated regulation of cancer cell survival with the NFkappaB pathway and identify c-Jun and Bcl-3 as reciprocal pivotal determinants of apoptosis versus survival respectively.
###end p 75
###begin title 76
Discussion
###end title 76
###begin title 77
Basal apoptosis versus stress-induced apoptosis
###end title 77
###begin p 78
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Reed1">[30]</xref>
The programmed regulation of apoptosis under basal physiological conditions is crucial for normal mammalian development and, in the adult, for normal cellular turnover in individual tissue types. A further level of apoptotic control is induced in response to stress. Indeed, much of our understanding of the regulation of apoptosis in mammalian cells is based upon studies in which cells are analysed following exposure to defined stress conditions. From such studies it is becoming clear that different apoptotic programs are induced by different stimuli and are governed by cell type and physiological context [30].
###end p 78
###begin p 79
In contrast to stress-induced apoptosis, the intrinsic regulation of apoptosis under basal conditions is poorly understood. To address this problem we have investigated cells in the absence of applied stress and explored the regulatory balance governing basal cell survival versus apoptosis. Such information is particularly important for understanding disease processes including cancer in which regulatory failure of basal apoptosis permits de-regulated growth and survival of cells in vivo.
###end p 79
###begin title 80
Basal cancer cell survival involves a novel apoptotic network
###end title 80
###begin p 81
###xml 505 511 501 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g009">Fig. 9</xref>
###xml 516 523 512 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g010">Fig. 10</xref>
###xml 955 962 951 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 967 973 963 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g009">Fig. 9</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
Our results indicate that JNK2 is required for the survival of a range of human cancer cells cultured in the absence of applied stress. They also place JNK2 upstream of a novel regulatory network in which apoptosis (i) is driven by co-ordinated pro-apoptotic functions of JNK1 and c-Jun, (ii) is primed under basal conditions, (iii) is constitutively suppressed by JNK2, (iv) is linked with the NFkappaB survival pathway via Bcl-3/c-Jun, and (v) is mechanistically distinct from stress-induced apoptosis (Fig. 9 and Fig. 10). Moreover, the basal pro-apoptotic functions of JNK1 and c-Jun appear active despite the absence of site-specific phosphorylations known to be required for activation in response to stress. Following JNK2 depletion hypo-phosphorylated c-Jun protein translocates to the nucleus where it accumulates in the insoluble fraction and autoregulates its own expression. These changes in c-Jun are dependent upon hypo-phosphorylated JNK1 (Results and Fig. 9).
###end p 81
###begin title 82
###xml 18 23 <span type="species:ncbi:9606">human</span>
Basal survival of human cancer cells involves JNK2 suppression of a novel pro-apoptotic pathway.
###end title 82
###begin p 83
###xml 148 155 148 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
(A) JNK2 constitutively represses JNK1-mediated apoptosis. JNK1 is primed to initiate apoptosis which proceeds via the indicated intermediates (see Results). c-Jun dissociates from ITCH upon JNK2 depletion, loses S243P (*) and up-regulates its own transcription (*). (B) Distinctive characteristics of components of the MAP kinase pathway operating under basal conditions indicate that the regulation of apoptosis under basal conditions is mechanistically distinct from stress-induced apoptosis.
###end p 83
###begin title 84
Basal regulation of apoptosis involves a novel network regulated by JNK2 and mediated via JNK1, c-Jun and Bcl-3.
###end title 84
###begin p 85
###xml 322 332 322 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Discussion</xref>
###xml 337 343 337 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g009">Fig. 9</xref>
Hypothetical model for acquisition of an intrinsic apoptotic network in intestinal epithelial cells as they approach terminal differentiation. This network is subject to JNK2 which, abnormally, can enable cell survival and cancer via constitutive suppression of down-stream pro-apoptotic mediators under JNK1 control (see Discussion and Fig. 9).
###end p 85
###begin p 86
###xml 248 255 244 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
Downstream mediators of the basal pro-apoptotic pathway include components of the TNFalpha response pathway, namely ITCH, GSK3, ERK and Fbw7. However their functional interactions appear to be mechanistically distinct from those induced by stress (Results). This indicates that the regulation of basal cell survival/apoptosis is distinct from stress-induced apoptosis even though the same pro-apoptotic players are employed. It is possible that as yet uncharacterised protein-protein interactions govern basal apoptotic functions of hypo-phosphorylated JNK1, JNK2 and c-Jun. Such interactions may enable the formation of multi-protein complexes and basal apoptotic pathways distinct from those induced by stress.
###end p 86
###begin p 87
###xml 147 154 143 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g010">Fig. 10</xref>
###xml 431 438 427 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 624 631 620 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
Our results also indicate that the basal pro-apoptotic pathway is countered by the IkappaB protein Bcl-3. Once again JNK2 is the master regulator (Fig. 10). Mechanistically this is attributable to JNK2-mediated suppression of c-Jun, which we identify as down-regulator of Bcl-3 expression in HCT116 cancer cells. JNK2 depletion results in accumulation of c-Jun protein which, in turn, down-regulates Bcl-3 mRNA and protein levels (Results). Down-regulation of Bcl-3 directly impacts upon cell survival since we also demonstrate that RNAi-mediated depletion of Bcl-3 induces apoptosis despite the continued presence of JNK2 (Results).
###end p 87
###begin p 88
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Ohno1">[18]</xref>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Pratt1">[31]</xref>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Rebollo1">[32]</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Westerheide1">[33]</xref>
###xml 547 551 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Michel1">[17]</xref>
###xml 746 750 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Michel1">[17]</xref>
The involvement of Bcl-3 in the basal regulation of cancer cell survival versus apoptosis is particularly interesting, especially since Bcl-3 is already identified as a putative oncoprotein [18], [31], [32], [33]. Bcl-3 has an atypical domain structure for an IkappaB protein. This confers distinct functional properties for Bcl-3. For example, in contrast to IkappaBalpha and IkappaBbeta, the nuclear localisation signal on Bcl-3 lies outside the ankyrin repeat domain and enables transport of bound p50:p50 NFkappaB homodimers into the nucleus ([17] and references therein). Also, the seventh ankyrin repeat of Bcl-3, missing on IkappaBalpha and IkappaBbeta, has been identified as a good candidate for interaction with the minor groove of DNA [17], possibly accounting for Bcl-3 complexing with DNA-bound NFkappaB homodimers.
###end p 88
###begin p 89
The functional significance of Bcl-3 is unknown. Our discovery that this unusual IkappaB protein is reciprocally linked with JNK1/c-Jun in the basal regulation of apoptosis raises the possibility that Bcl-3 may function selectively under basal physiological conditions. Thus, during evolution, the functioning of Bcl-3 and IkappaBalpha/IkappaBbeta may have diverged to regulate cell survival under basal versus stress-induced conditions respectively.
###end p 89
###begin title 90
Cancer versus non-cancer cells
###end title 90
###begin p 91
###xml 132 139 132 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 144 150 144 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g001">Fig. 1</xref>
###xml 217 229 217 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 698 705 698 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 705 709 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Dunn1">[34]</xref>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Philp1">[35]</xref>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 377 382 <span type="species:ncbi:9606">human</span>
Comparison of cancer and non-cancer cell lines indicates that the JNK2 requirement for cell survival is restricted to cancer cells (Results and Fig. 1). This is consistent with the reported viability of JNK2-/- mice (Introduction). For more in-depth comparison of cancer versus non-cancer cells we used HCT116 p53+/+ and ARPE19 cell lines. HCT116 p53+/+ are well characterised human epithelial colorectal cancer cells and have a stable karyotype. ARPE19 cells are partially differentiated retinal pigmented epithelial cells derived from non-cancerous tissue. ARPE19 have a normal karyotype and retain many of the structural and physiological properties of normal retinal pigmented epithelial cells in vivo[34], including polarised membrane expression of monocarboxylate transporters [35].
###end p 91
###begin p 92
###xml 465 472 465 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 474 480 474 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Fig. 8</xref>
###xml 485 492 485 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007305.s006">Fig. S5</xref>
Our results demonstrate that HCT116 cancer cells are primed to undergo basal apoptosis in response to (i) JNK2 depletion, (ii) Bcl-3 depletion or (iii) exogenous over-expression of c-Jun. In contrast the ARPE19 non-cancer cells were refractory to each of these three conditions. These cancer-related differences may reflect differences in sub-cellular localisations of pro- and anti-apoptotic proteins such as c-Jun and Bcl-3 in cancer versus non-cancer cells (see Results, Fig. 8 and Fig. S5). Cancer-related differences in spatial proteomic fluxes may also influence the balance between pro- and anti-apoptotic effectors under basal conditions.
###end p 92
###begin p 93
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Fantin1">[36]</xref>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Bordone1">[37]</xref>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Grummt1">[38]</xref>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Allison1">[21]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Ford1">[22]</xref>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Brooks1">[39]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Ford2">[40]</xref>
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Bordone1">[37]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Brooks1">[39]</xref>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Ford1">[22]</xref>
###xml 558 563 <span type="species:ncbi:9606">human</span>
Another possibility is that altered metabolism and aerobic glycolysis, characteristic of cancer cells [36], also impact upon pro- and anti-apoptotic systems. In this context it is interesting to note that nucleolar JNK2 and SIRT1 proteins are both responsive to metabolic stress [37], [38] and both are also identified as cancer-related survival factors ([21], [22], [39], [40] and this present work). SIRT1 is an NAD-dependent de-acetylase and key regulator of aging, metabolism and homeostasis [37], [39]. SIRT1 protein turnover appears subject to JNK2 in human cell lines [22]. As yet the significance of this is unknown.
###end p 93
###begin p 94
###xml 776 783 772 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g010">Fig. 10</xref>
###xml 1040 1047 1036 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
Cellular differentiation may also affect the balance of basal pro- and anti-apoptotic networks. For example, normal intestinal epithelial cells presumably become intrinsically primed to undergo basal apoptosis as a part of the normal process of cellular turnover. This process must be under stringent temporal control in order to prevent premature apoptosis on one hand, and to prevent delayed apoptosis and abnormal cellular accumulation on the other hand. On the basis of our current observations we suggest that components of the JNK and NFkappaB pathways may be exploited and co-ordinated to achieve this effect. We hypothesise that the basal JNK1/c-Jun pro-apoptotic pathway may be held in check by JNK2 until terminal apoptosis is required (represented schematically in Fig. 10). We further propose that during earlier stages of differentiation the JNK2/JNK1/c-Jun apoptotic network is non-operational. This would minimise the risk of premature apoptosis and also explain the observed resistance of undifferentiated non-cancer cells (Results) to JNK2 silencing or over-expression of c-Jun. However, at all stages of differentiation the cells are able to respond to stress since they express JNK and NFkappaB pathways which can be activated by stress-induced kinase signalling.
###end p 94
###begin p 95
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Tong1">[20]</xref>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 547 552 <span type="species:ncbi:9606">human</span>
According to the above model for intrinsic apoptosis it is predicted that failure to engage the basal JNK1/c-Jun pro-apoptotic mechanism would compromise normal apoptotic turnover and so favour tumour formation. Indeed, this is exactly what is observed in JNK1-/- mice which exhibit pre-disposition to intestinal tumour formation [20]. Failure to alleviate JNK2-mediated suppression of JNK1/c-Jun would similarly favour tumour formation, and this is supported by our evidence for constitutive JNK2-mediated suppression of JNK1/c-Jun in a range of human colorectal cancer cell lines (this paper).
###end p 95
###begin p 96
###xml 367 372 <span type="species:ncbi:9606">human</span>
In summary, the link between JNK2/JNK1/c-Jun and Bcl-3 identifies pivotal roles for these proteins in the basal regulation of apoptosis versus cell survival. The discovery of a novel apoptotic network governing basal cell survival is crucial for understanding the intrinsic regulation of normal cellular turnover and opens new avenues for therapeutic intervention in human proliferative disease states.
###end p 96
###begin title 97
Materials and Methods
###end title 97
###begin title 98
Cell lines and transfection
###end title 98
###begin p 99
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 107 110 107 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 115 118 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 131 134 131 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Jaeschke1">[2]</xref>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Bunz1">[41]</xref>
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Allison1">[21]</xref>
###xml 591 595 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Ford1">[22]</xref>
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 249 254 <span type="species:ncbi:9606">Human</span>
Epithelial cancer cell lines used include human colorectal carcinoma HCT116 isogenic clones (p53+/+ and p53-/-; Bax+/- and Bax-/-) [2], [41]; LoVo and RKO (wt p53), HT29 (mutant p53); breast carcinoma: MCF7 (wt p53) and osteosarcoma: U2OS (wt p53). Human non-cancer cell lines include ARPE-19 (retinal epithelial) and WI-38 (lung fibroblasts) and MCF7 10A (breast epithelial). MCF7 10A were grown in MEGM media supplemented with 100 ng/mL cholera toxin in the absence of FCS. Other cells lines were maintained and transfected using synthetic siRNAs (Dharmacon) as described previously [21], [22].
###end p 99
###begin title 100
siRNA sequences and mRNA quantification
###end title 100
###begin p 101
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Ford1">[22]</xref>
###xml 206 234 206 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007305.s001">Supplementary Information S1</xref>
Two independent siRNA target, previously validated for JNK1 or JNK2 [22] were used. siRNA's were typically used at a final concentration of 100 nM. Additional siRNA and primer sequences are provided in the Supplementary Information S1. Total RNA was isolated using RNeasy kit (Qiagen) following manufactures protocol and mRNA levels was measured by quantitative PCR using MJ DNA Engine Opticon with Qiagen SYBRgreen Quantitect kit. At least three determinations of mRNA levels were made.
###end p 101
###begin title 102
Immunoprecipitation and Immunoblotting
###end title 102
###begin p 103
###xml 238 241 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">183</sup>
###xml 246 249 246 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">185</sup>
For immunoblotting whole cell lysates were prepared and processed in SDS buffer. Antibodies: anti-JNK1 (F-3), anti-c-Jun (sc-45), anti-c-Jun-p63 (KM-1), anti-p53 (DO-1), GSK3 (sc-7291) all Santa Cruz; JNK2, dual anti-phospho-SAPK/JNK (Thr183, Tyr185), anti-cleaved caspase 3, anti-caspase 7, anti-caspase 8, anti-c-Jun-p91, anti-c-Jun-p243, anti-FLIP, all Cell Signalling. Anti-c-Jun-p239 antibody (Abcam) was unable to detect c-Jun-239 phosphorylation under basal conditions or following JNK2 silencing. Bcl-3 (C-14) from Santa Cruz; NFkappaB p65 (3034) and NFkappaB p105/50 (3035) from Cell Signalling; ERK (9B3) and NFkappaB p100/52 from Abcam. c-Jun Ser63 phosphorylation antibody (KM-1, Santa Cruz). Anti-p21 (Pharmingen), anti-c-Jun-p73 (Upstate), and anti-ITCH (BD Transduction). Actin (AC40, Sigma) was used as an internal loading control throughout all experiments. Visualisation of bound antibodies was carried out using enhanced chemiluminescence kit (Roche).
###end p 103
###begin p 104
For detection of c-Jun/ITCH protein complexes HCT116 p53+/+ cells were lysed in cold IP buffer (50 mM Tris pH 8, 150 mM NaCl, 1% NP40, 10 mM EDTA), in the presence of protease cocktail inhibitor (Roche), sonicated and centrifuged. The supernatant was percleared with protein G sephearse beads (Sigma) followed by assay of total protein (BCA kit, Pierce). 800 microg of total lysate was immunoprecipitated overnight at 4degreesC with 6 microg of c-Jun antibody (sc-45, Santa Cruz). Controls included c-Jun antibody with IP buffer only (no lysate), and IgG control. Immunocomplexes were captured with protein G sephearse, washed and eluted in denaturing SDS buffer. Eluates were immunoblotted for ITCH (BD Transduction) and c-Jun (Upstate).
###end p 104
###begin title 105
Chromatin Immunoprecipitation (ChIP)
###end title 105
###begin p 106
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 120 122 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 219 247 219 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007305.s001">Supplementary Information S1</xref>
ChIP was performed according to manufacturers protocol (EZ ChIP, Upsate). HCT116 p53+/+ cells were irradiated with 20 Jm-2 UV for 4 hours, or transfected with JNK2 siRNA for 48 hours. Additional details are provided in Supplementary Information S1.
###end p 106
###begin title 107
Stress treatment and apoptosis
###end title 107
###begin p 108
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
Cells were treated with 20 Jm-2 UV for 4 h, or TNF-alpha (Calbiochem) at final concentration of 20 ng/mL at time points indicated. Apoptotic cells were identified by fluorescence activated cell sorting (FACS) using Annexin V-Fluos (Roche). Caspase 8, caspase 7 and caspase 3 were determined by immunoblotting.
###end p 108
###begin title 109
Nuclear and Cytoplasmic Extraction
###end title 109
###begin p 110
Nuclear and cytoplasmic extraction was carried out using NE-PER kit (Pierce) according to manufactures instructions. Distribution of each protein is from a total of 750, 000 cells. The nuclear insoluble fraction employs a different buffer to the nuclear soluble fraction and accounting for slight changes in protein migration.
###end p 110
###begin title 111
Plasmids and overexpression studies
###end title 111
###begin p 112
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Wei1">[10]</xref>
###xml 284 288 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007305-Ford1">[22]</xref>
###xml 615 643 609 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007305.s001">Supplementary Information S1</xref>
###xml 22 27 <span type="species:ncbi:9606">human</span>
Flag tagged wild type human c-Jun and mutant c-Jun constructs have been described previously [10]. Mutant c-Jun contained (S63/S73 and T91/T93--> A substitutions). Transfection was carried out with 1 microg of empty vector (PC3.1, control) or c-Jun constructs as described previously [22] for 28 hours. Apoptosis was detected using annexin V labelling as described earlier. For combined overexpression and siRNA studies, cells were transfected with c-Jun (T91/93) siRNA as described earlier for 24 hours followed by transfection of empty control vector or mutant c-Jun construct (non recognisable to the siRNA, see Supplementary Information S1) for 24 hours.
###end p 112
###begin title 113
Supporting Information
###end title 113
###begin p 114
Additional methods and supporting references
###end p 114
###begin p 115
(0.05 MB DOC)
###end p 115
###begin p 116
Click here for additional data file.
###end p 116
###begin p 117
###xml 288 309 288 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
JNK2 constitutively suppresses JNK1 mediated apoptosis. Knock-down of JNK2 using a second independent siRNA causes apoptosis. This is rescued by a co-silencing with a second siRNA directed against JNK1. These results are consistent with the JNK1 and JNK2 siRNA used this study, (see also Materials and Methods).
###end p 117
###begin p 118
(0.58 MB TIF)
###end p 118
###begin p 119
Click here for additional data file.
###end p 119
###begin p 120
JNK1 and JNK2 levels are unaffected by BCR-ABL or Lamin A/C siRNA treatment. Lamin A/C siRNA causes specific knock-down of Lamin A/C without affecting JNK1/JNK2 levels. BCR-ABL siRNA (BCR) has no target in the cell lines used in this investigation (negative control). The "stress sensor" p53 is not activated following transfection of an active (Lamin A/C) or inactive (BCR-ABL) siRNA.
###end p 120
###begin p 121
(1.06 MB TIF)
###end p 121
###begin p 122
Click here for additional data file.
###end p 122
###begin p 123
JNK upstream kinases MKK4 and MKK7 are dispensable for JNK2 siRNA induced apoptosis in HCT116 p53+/+ cells. JNK2 siRNA mediated apoptosis was not rescued by co-silencing with MKK4 and was only partially rescued following combined MKK7 and JNK2 siRNA treatment.
###end p 123
###begin p 124
(0.99 MB TIF)
###end p 124
###begin p 125
Click here for additional data file.
###end p 125
###begin p 126
Knock-down of JNK1 causes attenuation of c-Jun protein levels. The c-Jun blots in main figures have been under exposed to measure induction of c-Jun.
###end p 126
###begin p 127
(0.99 MB TIF)
###end p 127
###begin p 128
Click here for additional data file.
###end p 128
###begin p 129
###xml 301 310 301 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007305-g008">Figure 8A</xref>
###xml 315 325 315 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Discussion</xref>
Apoptotic regulators fractionate into different compartments in ARPE-19 non-cancer cells. c-Jun and Bcl-3 localise in both the nuclear soluble and nuclear insoluble fractions under basal conditions compared to HCT116 p53+/+ cells where they are found exclusively in the nuclear soluble fraction, (see Figure 8A and Discussion).
###end p 129
###begin p 130
(1.18 MB TIF)
###end p 130
###begin p 131
Click here for additional data file.
###end p 131
###begin p 132
We thank members of the YCR p53 Research unit for valuable discussions. We are grateful to Bert Volgelstein for generously making available the HCT116 p53+/+ and p53-/-, and Bax+/- and Bax-/- isogenic clones, and to William G Kaelin for the c-Jun expression constructs.
###end p 132
###begin title 133
References
###end title 133
###begin article-title 134
Mammalian MAP kinase signalling cascades.
###end article-title 134
###begin article-title 135
JNK2 is a positive regulator of the cJun transcription factor.
###end article-title 135
###begin article-title 136
Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.
###end article-title 136
###begin article-title 137
Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase.
###end article-title 137
###begin article-title 138
Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.
###end article-title 138
###begin article-title 139
BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.
###end article-title 139
###begin article-title 140
AP-1 subunits: quarrel and harmony among siblings.
###end article-title 140
###begin article-title 141
Phosphorylation of c-jun mediated by MAP kinases.
###end article-title 141
###begin article-title 142
Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73.
###end article-title 142
###begin article-title 143
The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase.
###end article-title 143
###begin article-title 144
TNF and cancer: the two sides of the coin.
###end article-title 144
###begin article-title 145
Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change.
###end article-title 145
###begin article-title 146
Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death.
###end article-title 146
###begin article-title 147
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.
###end article-title 147
###begin article-title 148
The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.
###end article-title 148
###begin article-title 149
Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
###end article-title 149
###begin article-title 150
Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family.
###end article-title 150
###begin article-title 151
The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control.
###end article-title 151
###begin article-title 152
Defective T cell differentiation in the absence of Jnk1.
###end article-title 152
###begin article-title 153
c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression.
###end article-title 153
###begin article-title 154
SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways.
###end article-title 154
###begin article-title 155
JNK2-dependent regulation of SIRT1 protein stability.
###end article-title 155
###begin article-title 156
JNK targets p53 ubiquitination and degradation in nonstressed cells.
###end article-title 156
###begin article-title 157
JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun.
###end article-title 157
###begin article-title 158
Transcriptional repression of c-Jun's E3 ubiquitin ligases contributes to c-Jun induction by UV.
###end article-title 158
###begin article-title 159
A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun.
###end article-title 159
###begin article-title 160
The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase.
###end article-title 160
###begin article-title 161
BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak.
###end article-title 161
###begin article-title 162
c-FLIP: a key regulator of colorectal cancer cell death.
###end article-title 162
###begin article-title 163
The domains of apoptosis: a genomics perspective.
###end article-title 163
###begin article-title 164
Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence.
###end article-title 164
###begin article-title 165
Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors.
###end article-title 165
###begin article-title 166
The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition.
###end article-title 166
###begin article-title 167
###xml 11 16 <span type="species:ncbi:9606">human</span>
ARPE-19, a human retinal pigment epithelial cell line with differentiated properties.
###end article-title 167
###begin article-title 168
###xml 56 61 <span type="species:ncbi:9606">human</span>
Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells.
###end article-title 168
###begin article-title 169
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.
###end article-title 169
###begin article-title 170
Calorie restriction, SIRT1 and metabolism: understanding longevity.
###end article-title 170
###begin article-title 171
A metabolic throttle regulates the epigenetic state of rDNA.
###end article-title 171
###begin article-title 172
How does SIRT1 affect metabolism, senescence and cancer?
###end article-title 172
###begin article-title 173
###xml 42 47 <span type="species:ncbi:9606">human</span>
Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.
###end article-title 173
###begin article-title 174
Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
###end article-title 174
###begin p 175
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 175
###begin p 176
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This project was supported by a Yorkshire Cancer Research core research programme award to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 176

